{"id":208172,"name":"CHIESI USA, INC.","slug":"chiesi-usa-inc","state":"NC","country":"United States of America","description":"Specialty pharmaceutical company; develops products for rare disease and specialty care","totalSpending":390000,"filings":15,"yearlySpending":[{"year":2020,"income":30000},{"year":2021,"income":120000},{"year":2022,"income":120000},{"year":2023,"income":120000},{"year":2024,"income":0}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"HCR","display":"Health Issues"}],"firms":["THE KPM GROUP DC LLC"],"lobbyists":["PATROSKI LAWSON","BENJAMIN MASON","KATHERINE LANDES","JACOB JACKSON","ALEXANDER ROOT"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","White House Office"],"sampleDescriptions":["Priority Review Voucher Program; FDA international inspections","Priority Review Voucher Program; FDA international inspections","FDA Inspections","H.R. 1730/S. 670, the Speeding Therapy Access Today (STAT) Act\nH.R. 2623, Camerons Law\nMACPAC Accelerated Approval Pathway Recommendations\nCures 2.0 (not introduced yet)","H.R. 6000, Cures 2.0 Act\nH.R. 5376, the Build Back Better Act\nH.R. 2623, Camerons Law\nH.R. 482/ S. 350, the Newborn Screening Saves Lives Reauthorization Act"]}